We propose the development of tools that can help identify cognitively normal subjects at risk for developing Alzheimer’s Disease (AD). The tests will use small volumes of peripheral fluids (blood, saliva, urine). Our goal is to evaluate the potential of exosomes to be used as “carriers of AD biomarkers”. These markers will be essential for […]
Read More